Chinook Therapeutics Inc.

NASDAQ: KDNY · Real-Time Price · USD
40.39
0.09 (0.22%)
At close: Aug 10, 2023, 10:00 PM

Chinook Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2022 FY 2021
Period Ending Dec 31, 2022 Dec 31, 2021
PE Ratio
-9.14 -7.34
PEG Ratio
-0.31 0.11
PS Ratio
275.21 14.41
PB Ratio
3.82 1.64
P/FCF Ratio
-14.16 -7.11
P/OCF Ratio
-14.36 -7.24
OCF/S Ratio
-19.17 -1.99
Debt / Equity Ratio
0.09 0.10
Quick Ratio
7.59 7.50
Current Ratio
7.59 7.50
Asset Turnover
0.01 0.09
Interest Coverage
-25.78 n/a
Return on Equity
-0.42 -0.22
Return on Assets
-0.32 -0.18
Return on Invested Capital
-0.36 -0.19
Dividend Yield
n/a n/a
Payout Ratio
n/a n/a
Gross Profit Margin
0.72 0.97
Net Profit Margin
-30.13 -1.96
Pretax Profit Margin
-29.42 -1.92
Operating Profit Margin
-30.2 -1.92
FCF Margin
n/a n/a
EBITDA Margin
-26.79 -1.11